A Prospective Randomized Trial on Mycophenolate Mofetil in Risk Penetrating Keratoplasty

NCT00411515 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Corneal Transplantation

Interventions

DRUG: Mycophenolate Mofetil 2x 1g

Sponsor

University Hospital Freiburg

Collaborators

[object Object]